- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01922557
Thoracic Fluid Content and Acute Lung Injury
August 12, 2013 updated by: National Taiwan University Hospital
The Association of Thoracic Fluid Content and Acute Lung Injury in Liver Transplantation
To study the association of the thoracic fluid content and acute lung injury during liver transplantation.
Study Overview
Detailed Description
Acute lung injury is not uncommon after liver transplantation.
A new monitor non-invasive cardiac output monitor (NICOM) is designed to measure thoracic fluid content.
The investigators attempt to use the parameter thoracic fluid content to investigate its relationship with acute lung injury in liver transplant recipients.
Study Type
Observational
Enrollment (Actual)
22
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 100
- Department of Anesthesiology, NTUH
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
end stage liver disease patients scheduled for liver transplantation in National Taiwan University Hospital were enrolled.
Description
Inclusion Criteria:
- end stage liver disease scheduled for liver transplantation in National Taiwna University Hospital.
Exclusion Criteria:
- allergic reaction
- history of aortic regurgitation
- pre-existing pulmonary disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
NICOM
|
NICOM monitoring thoracic fluid content at baseline(T1), anhepatic phase(T2), 30 mins after reperfusion(T3) and 2 hrs after reperfusion(T4).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiac index
Time Frame: one day
|
Participants will be followed for the duration the operation.
Cardiac index was measured by non-invasive cardiac output monitor at different time points as baseline(T1), anhepatic phase(T2), 30 mins after reperfusion(T3) and 2 hrs after reperfusion(T4)
|
one day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Thoracic fluid content
Time Frame: one day
|
Participants will be followed for the duration the operation.Thoracic fluid content was measured in liver transplant recipients at different time points as baseline(T1), anhepatic phase(T2), 30 mins after reperfusion(T3) and 2 hrs after reperfusion(T4).
|
one day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2011
Primary Completion (Actual)
January 1, 2011
Study Completion (Actual)
June 1, 2012
Study Registration Dates
First Submitted
July 11, 2013
First Submitted That Met QC Criteria
August 12, 2013
First Posted (Estimate)
August 14, 2013
Study Record Updates
Last Update Posted (Estimate)
August 14, 2013
Last Update Submitted That Met QC Criteria
August 12, 2013
Last Verified
August 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201012081RC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Lung Injury
-
Yangzhou UniversityCompleted
-
Taipei Medical University WanFang HospitalUnknown
-
Damanhour UniversityAlexandria UniversityCompletedAcute Lung Injury, Transfusion RelatedEgypt
-
Virginia Commonwealth UniversityCompletedCOVID-19 | Kidney Injury | Lung Injury, AcuteUnited States
-
Kocaeli UniversityCompletedVentilator-Induced Lung Injury | Ventilator Adverse Event | Lung Injury, AcuteTurkey
-
All India Institute of Medical Sciences, RishikeshUnknownLung Injury, Acute
-
GlaxoSmithKlineCompleted
-
Vanderbilt UniversityTerminated
-
Children's Hospital of PhiladelphiaNational Heart, Lung, and Blood Institute (NHLBI)Completed
Clinical Trials on NICOM
-
Indiana UniversityCheetah Medical Inc.CompletedFluid Overload | Hypovolemia
-
University of MinnesotaRecruitingSepsis | Septic Shock | HypotensionUnited States
-
Hopital FochCompletedEpidural Analgesia | LaborFrance
-
National University Hospital, SingaporeSingapore Clinical Research InstituteCompletedSepsis | Shock, SepticSingapore
-
Charite University, Berlin, GermanyBayer; Health Twist GmbHCompletedHeart Failure | Hypertension | Diabetic Nephropathies | Hypertension, PulmonaryGermany
-
Olive View-UCLA Education & Research InstituteUniversity of California, Los AngelesCompletedSepsis | Fluid Overload | HypovolemiaUnited States
-
Maisonneuve-Rosemont HospitalUnknownPeripheral Arterial Disease | Aortic AneurysmCanada
-
Mayo ClinicCompleted
-
Universitätsmedizin MannheimCompleted